Christoph U Correll (C U Correll)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 65

Top Topics

Roux En Y Gastric Bypass

Systematic Review

Bipolar Disorder

Top Venues

Expert opinion on investigational drugs

Neuropsychiatric disease and treatment

Acta psychiatrica Scandinavica

This page only lists publications with an associated author ORCID identifier.

Publications

Jose M Rubio, Daniel Guinart, John M Kane, Christoph U Correll
Early Non-Response to Antipsychotic Treatment in Schizophrenia: A Systematic Review and Meta-Analysis of Evidence-Based Management Options. CNS drugs (2023)
Mikkel Hojlund, Kjeld Andersen, Martin Thomsen Ernst, Christoph U Correll, Nina Sahlertz Kristiansen
Response to: The use of low-dose quetiapine does not necessarily increase the risk of major adverse cardiovascular events. Acta neuropsychiatrica (2023)
Bettina Frank, Sabine Arnold, Charlotte Jaite, Christoph U Correll
Antipsychotic effects on anthropometric outcomes in anorexia nervosa: a retrospective chart review of hospitalized children and adolescents. Journal of eating disorders 11 (1) (2023)
Mark S Todtenkopf, Christoph U Correll, Marni E Harris-White, Michael J Doane, David McDonnell
Comment on "Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review". The mental health clinician 13 (4) (2023)
Sabine Arnold, Christoph U Correll, Charlotte Jaite
Frequency and correlates of lifetime suicidal ideation and suicide attempts among consecutively hospitalized youth with anorexia nervosa and bulimia nervosa: results from a retrospective chart review. Borderline personality disorder and emotion dysregulation 10 (1) (2023)
Fabian Huth, Leonardo Tozzi, Michael Marxen, Philipp Riedel, Kyra Bröckel, Julia Martini, Christina Berndt, Cathrin Sauer, Christoph Vogelbacher, Andreas Jansen, Tilo T J Kircher, Irina Falkenberg, Florian Thomas-Odenthal, Martin Lambert, Vivien Kraft, Gregor Leicht, Christoph Mulert, Andreas J Fallgatter, Thomas Ethofer, Anne Rau, Karolina Leopold, Andreas Bechdolf, Andreas Reif, Silke Matura, Silvia Biere, Felix Bermpohl, Jana Fiebig, Thomas Stamm, Christoph U Correll, Georg Juckel, Vera Flasbeck, Philipp S Ritter, Michael Bauer, Andrea Pfennig, Pavol Mikolas
Machine Learning Prediction of Estimated Risk for Bipolar Disorders Using Hippocampal Subfield and Amygdala Nuclei Volumes. Brain sciences 13 (6) (2023)
Laura M Watrin-Avino, Franziska J Forbes, Martin C Buchwald, Katja Dittrich, Christoph U Correll, Felix Bermpohl, Katja Bödeker
Affect Recognition, Theory of Mind, and Empathy in Preschool Children with Externalizing Behavior Problems-A Group Comparison and Developmental Psychological Consideration. Children (Basel, Switzerland) 10 (9) (2023)
Christoph U Correll, Andreas Brieden, Wolfgang Janetzky
Symptomatic, functional and quality of life measures of remission in 194 outpatients with schizophrenia followed naturalistically in a 6-month, non-interventional study of aripiprazole once-monthly. Schizophrenia (Heidelberg, Germany) 9 (1) (2023)
Mikkel Hojlund, Kjeld Andersen, Martin Thomsen Ernst, Christoph U Correll, Nina Sahlertz Kristiansen
Response to: The use of low-dose quetiapine does not necessarily increase the risk of major adverse cardiovascular events. Acta neuropsychiatrica 35 (1) (2023)
Peter M Haddad, Christoph U Correll
Long-acting antipsychotics in the treatment of schizophrenia: opportunities and challenges. Expert opinion on pharmacotherapy (2023)
Sara Jiménez-Fernández, Manuel Gurpegui, Christoph U Correll, Jose De Leon, Georgios Schoretsanitis
A Systematic Review of Clozapine Concentration-Dose Ratio from Therapeutic Drug Monitoring Studies in Children and Adolescents Treated with Clozapine for Mental Disorders. Therapeutic drug monitoring (2023)
Michael Frey, Lukasz Smigielski, Elvira Tini, Stefanie Fekete, Christian Fleischhaker, Christoph Wewetzer, Andreas Karwautz, Christoph U Correll, Manfred Gerlach, Regina Taurines, Paul L Plener, Uwe Malzahn, Selina Kornbichler, Laura Weninger, Matthias Brockhaus, Su-Yin Reuter-Dang, Karl Reitzle, Hans Rock, Hartmut Imgart, Peter Ulrich Heuschmann, Stefan Unterecker, Wolfgang Briegel, Tobias Banaschewski, Jörg M Fegert, Tobias Hellenschmidt, Michael Kaess, Michael G Kölch, Tobias Renner, Christian Rexroth, Susanne Walitza, Gerd Schulte-Körne, Marcel Romanos, Karin Maria Egberts
Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL Trial. Pharmaceutics 15 (9) (2023)
Sabine Arnold, Christoph U Correll, Charlotte Jaite
Frequency and correlates of lifetime suicidal ideation and suicide attempts among consecutively hospitalized youth with anorexia nervosa and bulimia nervosa: results from a retrospective chart review. Borderline personality disorder and emotion dysregulation 10 (1) (2023)
Sabine Arnold, Christoph U Correll, Charlotte Jaite
Frequency and correlates of lifetime suicidal ideation and suicide attempts among consecutively hospitalized youth with anorexia nervosa and bulimia nervosa: results from a retrospective chart review. Borderline personality disorder and emotion dysregulation 10 (1) (2023)
Mikkel Hojlund, Kjeld Andersen, Martin Thomsen Ernst, Christoph U Correll, Nina Sahlertz Kristiansen
Response to: The use of low-dose quetiapine does not necessarily increase the risk of major adverse cardiovascular events. Acta neuropsychiatrica 35 (1) (2023)
Jonathan M Meyer, Christoph U Correll
Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia. CNS drugs (2023)
Robert Litman, Dieter Naber, Lourdes Anta, Javier Martínez, Yuriy Filts, Christoph U Correll
Personal and Social Functioning and Health-Related Quality of Life in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Risperidone ISM. Neuropsychiatric disease and treatment 19 (2023)
Sabine Arnold, Christoph U Correll, Charlotte Jaite
Frequency and correlates of lifetime suicidal ideation and suicide attempts among consecutively hospitalized youth with anorexia nervosa and bulimia nervosa: results from a retrospective chart review. Borderline personality disorder and emotion dysregulation 10 (1) (2023)
Fabian Huth, Leonardo Tozzi, Michael Marxen, Philipp Riedel, Kyra Bröckel, Julia Martini, Christina Berndt, Cathrin Sauer, Christoph Vogelbacher, Andreas Jansen, Tilo T J Kircher, Irina Falkenberg, Florian Thomas-Odenthal, Martin Lambert, Vivien Kraft, Gregor Leicht, Christoph Mulert, Andreas J Fallgatter, Thomas Ethofer, Anne Rau, Karolina Leopold, Andreas Bechdolf, Andreas Reif, Silke Matura, Silvia Biere, Felix Bermpohl, Jana Fiebig, Thomas Stamm, Christoph U Correll, Georg Juckel, Vera Flasbeck, Philipp S Ritter, Michael Bauer, Andrea Pfennig, Pavol Mikolas
Machine Learning Prediction of Estimated Risk for Bipolar Disorders Using Hippocampal Subfield and Amygdala Nuclei Volumes. Brain sciences 13 (6) (2023)
Mikkel Hojlund, Kjeld Andersen, Martin Thomsen Ernst, Christoph U Correll, Nina Sahlertz Kristiansen
Response to: The use of low-dose quetiapine does not necessarily increase the risk of major adverse cardiovascular events. Acta neuropsychiatrica 35 (1) (2023)
Robert Litman, Dieter Naber, Lourdes Anta, Javier Martínez, Yuriy Filts, Christoph U Correll
Personal and Social Functioning and Health-Related Quality of Life in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Risperidone ISM. Neuropsychiatric disease and treatment 19 (2023)
Catalin Adrian Buzea, Lorena Dima, Christoph U Correll, Peter Manu
Drug-drug interactions involving antipsychotics and antihypertensives. Expert opinion on drug metabolism & toxicology 18 (4) (2022)
Christoph U Correll, Amber Martin, Charmi Patel, Carmela Benson, Rebecca Goulding, Jennifer Kern-Sliwa, Kruti Joshi, Emma Schiller, Edward Kim
Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics. Schizophrenia (Heidelberg, Germany) 8 (1) (2022)
Christoph U Correll, Paolo Fusar-Poli, Stefan Leucht, Anne Karow, Nadja P Maric, Carmen Moreno, Merete Nordentoft, Andrea Raballo
Treatment Approaches for First Episode and Early-Phase Schizophrenia in Adolescents and Young Adults: A Delphi Consensus Report from Europe. Neuropsychiatric disease and treatment 18 (2022)
Catalin Adrian Buzea, Peter Manu, Lorena Dima, Christoph U Correll
Drug-drug interactions involving combinations of antipsychotic agents with antidiabetic, lipid-lowering, and weight loss drugs. Expert opinion on drug metabolism & toxicology (2022)
Mikkel Hojlund, Christoph U Correll
Ulotaront: a TAAR1/5-HT1A agonist in clinical development for the treatment of schizophrenia. Expert opinion on investigational drugs 31 (12) (2022)
Jose De Leon, Georgios Schoretsanitis, Robert Løvsletten Smith, Espen Molden, Anssi Solismaa, Niko Seppälä, Miloslav Kopeček, Patrik Švancer, Ismael Olmos, Carina Ricciardi, Celso Iglesias-Garcia, Ana Iglesias-Alonso, Edoardo Spina, Can-Jun Ruan, Chuan-Yue Wang, Gang Wang, Yi-Lang Tang, Shih Ku Lin, Hsien-Yuan Lane, Yong Sik Kim, Se Hyun Kim, Anto P Rajkumar, Dinora Fabiola González Esquivel, Helgi Jung-Cook, Trino Baptista, Christopher Rohde, Jimmi Nielsen, Hélène Verdoux, Clelia Quiles, Emílio J Sanz, Carlos de Las Cuevas, Dan Cohen, Peter F J Schulte, Aygün Ertuğrul, Elif Anıl Yağcıoğlu, Nitin Chopra, Betsy McCollum, Charles Shelton, Robert O Cotes, Arun R Kaithi, John M Kane, Saeed Farooq, Chee H Ng, John Bilbily, Christoph Hiemke, Carlos López-Jaramillo, Ian R McGrane, Fernando Lana, Chin-Bin Eap, Manuel Arrojo-Romero, Flavian Ş Rădulescu, Erich Seifritz, Susanna Every-Palmer, Chad A Bousman, Emmanuel Bebawi, Rahul Bhattacharya, Deanna L Kelly, Yuji Otsuka, Judit Lazary, Rafael Torres, Agustin Yecora, Mariano Motuca, Kit Wa Sherry Chan, Monica Zolezzi, Sami Ouanes, Domenico de Berardis, Sandeep Grover, Ric M Procyshyn, Richard A Adebayo, Oleg O Kirilochev, Andrey Soloviev, Konstantinos N Fountoulakis, Alina Wilkowska, Wiesław Jerzy Cubała, Muhammad Ayub, Alzira Silva, Raphael M Bonelli, Jose M Villagrán-Moreno, Jacqueline Mayoral-van Son, Henk S Temmingh, Eric H Decloedt, Maria R Pedro, Hiroyoshi Takeuchi, Masaru Tsukahara, Gerhard Gründer, Marina Šagud, Andreja Celofiga, Dragana Ignjatovic Ristic, Bruno B Ortiz, Helio Elkis, Antônio Pacheco Palha, Adrián LLerena, Emilio Fernandez-Egea, Dan J Siskind, Abraham Weizman, Rim Masmoudi, Shamin Mohd Saffian, Jonathan G Leung, Peter F Buckley, Stephen R Marder, Leslie Citrome, Oliver Freudenreich, Christoph U Correll, Daniel J Müeller
Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. Pharmacopsychiatry 55 (2) (2022)
Mikkel Hojlund, Christoph U Correll
Ulotaront: a TAAR1/5-HT1A agonist in clinical development for the treatment of schizophrenia. Expert opinion on investigational drugs 31 (12) (2022)
Mikkel Hojlund, Eeva-Liisa Røssell Johansen, Kjeld Andersen, Christoph U Correll, Nina Sahlertz Kristiansen
Impact of low-dose quetiapine-use on glycosylated hemoglobin, triglyceride and cholesterol levels. Acta psychiatrica Scandinavica (2022)
Mathilde Frahm Laursen, Christoph U Correll, Rasmus W Licht, María Rodrigo-Domingo, Anne Katrine Pagsberg, René Ernst Nielsen
Characteristics prior to and at time of diagnosis in pediatric bipolar disorder. Nordic journal of psychiatry (2022)
Mikkel Hojlund, Christoph U Correll
Ulotaront: a TAAR1/5-HT1A agonist in clinical development for the treatment of schizophrenia. Expert opinion on investigational drugs 31 (12) (2022)
Jose De Leon, Georgios Schoretsanitis, Can-Jun Ruan, Carlos de Las Cuevas, John M Kane, Christoph U Correll
An international clozapine titration guideline to increase its safety and move forward on the route started by German-speaking psychiatrists in the 1960s. European archives of psychiatry and clinical neuroscience 272 (4) (2022)
Jose De Leon, Can-Jun Ruan, Georgios Schoretsanitis, Christopher Rohde, Elif Anıl Yağcıoğlu, Trino Baptista, Oleg O Kirilochev, Carlos de Las Cuevas, Christoph U Correll
An international guideline with six personalised titration schedules for preventing myocarditis and pneumonia associated with clozapine. General psychiatry 35 (3) (2022)
Mikkel Hojlund, Christoph U Correll
Ulotaront: a TAAR1/5-HT1A agonist in clinical development for the treatment of schizophrenia. Expert opinion on investigational drugs (2022)
Søren Dinesen Østergaard, Pernille Kølbaek, Christoph U Correll
Scalability of the positive and negative syndrome scale: The role of diagnostic heterogeneity and inter-rater reliability. Acta psychiatrica Scandinavica 146 (4) (2022)
Mikkel Højlund, Christoph U Correll
Ulotaront: a TAAR1/5-HT1A agonist in clinical development for the treatment of schizophrenia. Expert opinion on investigational drugs (2022)
Christoph U Correll, Michael Tocco, Jay Hsu, Robert Goldman, Andrei Pikalov
Short-term Efficacy and Safety of Lurasidone Versus Placebo in Antipsychotic-Naïve vs. Previously Treated Adolescents with an Acute Exacerbation of Schizophrenia. European psychiatry : the journal of the Association of European Psychiatrists (2022)
Amanda M Lambert, Helen M Parretti, Emma Pearce, Malcolm J Price, Mark Robert Riley, Ronan Ryan, Natalie Tyldesley-Marshall, Tuba Saygın Avşar, Gemma Matthewman, Alexandra Lee, Khaled Ahmed, Maria Lisa Odland, Christoph U Correll, Marco Solmi, Tom Marshall
Temporal trends in associations between severe mental illness and risk of cardiovascular disease: A systematic review and meta-analysis. PLoS medicine 19 (4) (2022)
Janine Nadler, Christoph U Correll, Daniel Le Grange, Erin C Accurso, Verena Haas
The Impact of Inpatient Multimodal Treatment or Family-Based Treatment on Six-Month Weight Outcomes in Youth with Anorexia Nervosa: A Naturalistic, Cross-Continental Comparison. Nutrients 14 (7) (2022)
J Spiegel, Sabine Arnold, H Salbach, E G Gotti, E Pfeiffer, U Lehmkuhl, Christoph U Correll, Charlotte Jaite
Emotional abuse interacts with borderline personality in adolescent inpatients with binge-purging eating disorders. Eating and weight disorders : EWD (2021)
Jiří Anýž, Eduard Bakštein, Andrea Dally, Marián Kolenič, Jaroslav Hlinka, Tereza Hartmannová, Kateřina Urbanová, Christoph U Correll, Daniel Novák, Filip Španiel
Validity of the Aktibipo Self-rating Questionnaire for the Digital Self-assessment of Mood and Relapse Detection in Patients With Bipolar Disorder: Instrument Validation Study. JMIR mental health 8 (8) (2021)
Koen Demyttenaere, Nicolas Leenaerts, Károly Acsai, Barbara Sebe, István Laszlovszky, Ágota Barabássy, Laura Fonticoli, Balázs Szatmári, Willie Earley, György Németh, Christoph U Correll
Disentangling the symptoms of schizophrenia: Network analysis in acute phase patients and in patients with predominant negative symptoms. European psychiatry : the journal of the Association of European Psychiatrists (2021)
Samuele Cortese, Gonzalo Arrondo, Christoph U Correll, Marco Solmi
Beyond the p factor: Is there a d factor? JCPP advances 1 (4) (2021)
Jose De Leon, Georgios Schoretsanitis, Robert Løvsletten Smith, Espen Molden, Anssi Solismaa, Niko Seppälä, Miloslav Kopeček, Patrik Švancer, Ismael Olmos, Carina Ricciardi, Celso Iglesias-Garcia, Ana Iglesias-Alonso, Edoardo Spina, Can-Jun Ruan, Chuan-Yue Wang, Gang Wang, Yi-Lang Tang, Shih Ku Lin, Hsien-Yuan Lane, Yong Sik Kim, Se Hyun Kim, Anto P Rajkumar, Dinora Fabiola González Esquivel, Helgi Jung-Cook, Trino Baptista, Christopher Rohde, Jimmi Nielsen, Hélène Verdoux, Clelia Quiles, Emílio J Sanz, Carlos de Las Cuevas, Dan Cohen, Peter F J Schulte, Aygün Ertuğrul, Elif Anıl Yağcıoğlu, Nitin Chopra, Betsy McCollum, Charles Shelton, Robert O Cotes, Arun R Kaithi, John M Kane, Saeed Farooq, Chee H Ng, John Bilbily, Christoph Hiemke, Carlos López-Jaramillo, Ian R McGrane, Fernando Lana, Chin-Bin Eap, Manuel Arrojo-Romero, Flavian Ş Rădulescu, Erich Seifritz, Susanna Every-Palmer, Chad A Bousman, Emmanuel Bebawi, Rahul Bhattacharya, Deanna L Kelly, Yuji Otsuka, Judit Lazary, Rafael Torres, Agustin Yecora, Mariano Motuca, Kit Wa Sherry Chan, Monica Zolezzi, Sami Ouanes, Domenico de Berardis, Sandeep Grover, Ric M Procyshyn, Richard A Adebayo, Oleg O Kirilochev, Andrey Soloviev, Konstantinos N Fountoulakis, Alina Wilkowska, Wiesław Jerzy Cubała, Muhammad Ayub, Alzira Silva, Raphael M Bonelli, Jose M Villagrán-Moreno, Jacqueline Mayoral-van Son, Henk S Temmingh, Eric H Decloedt, Maria R Pedro, Hiroyoshi Takeuchi, Masaru Tsukahara, Gerhard Gründer, Marina Šagud, Andreja Celofiga, Dragana Ignjatovic Ristic, Bruno B Ortiz, Helio Elkis, Antônio Pacheco Palha, Adrián LLerena, Emilio Fernandez-Egea, Dan J Siskind, Abraham Weizman, Rim Masmoudi, Shamin Mohd Saffian, Jonathan G Leung, Peter F Buckley, Stephen R Marder, Leslie Citrome, Oliver Freudenreich, Christoph U Correll, Daniel J Müeller
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. Pharmacopsychiatry 55 (2) (2021)
Mikkel Hojlund, Jacob Harbo Andersen, Kjeld Andersen, Christoph U Correll, Nina Sahlertz Kristiansen
Use of antipsychotics in Denmark 1997-2018: a nation-wide drug utilisation study with focus on off-label use and associated diagnoses. Epidemiology and psychiatric sciences 30 (2021)
Christoph U Correll, Edward Kim, Jennifer Kern Sliwa, Wayne Hamm, Srihari Gopal, Maju Mathews, Raja Venkatasubramanian, Stephen R Saklad
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview. CNS drugs 35 (1) (2021)
Christoph U Correll, Kenneth S Koblan, Seth C Hopkins, Yan Li, null Heather Dworak, Robert Goldman, Antony Loebel
Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study. NPJ schizophrenia 7 (1) (2021)
Gonzalo Salazar de Pablo, Daniel Guinart, Christoph U Correll
What are the physical and mental health implications of duration of untreated psychosis? European psychiatry : the journal of the Association of European Psychiatrists 64 (1) (2021)
Christoph U Correll, Brittney R Starling, Michael Huss
Systematic review of transdermal treatment options in attention-deficit/hyperactivity disorder: implications for use in adult patients. CNS spectrums (2021)
Christoph U Correll, Robert L Findling, Michael Tocco, Andrei Pikalov, Ling Deng, Robert Goldman
Safety and effectiveness of lurasidone in adolescents with schizophrenia: results of a 2-year, open-label extension study. CNS spectrums (2020)
Sara Jiménez-Fernández, Manuel Gurpegui, Daniel Garrote-Rojas, Luis Gutiérrez-Rojas, María D Carretero, Christoph U Correll
Oxidative stress parameters and antioxidants in patients with bipolar disorder: Results from a meta-analysis comparing patients, including stratification by polarity and euthymic status, with healthy controls. Bipolar disorders 23 (2) (2020)
Karolina Leopold, Michael Bauer, Andreas Bechdolf, Christoph U Correll, Martin Holtmann, Georg Juckel, Martin Lambert, Thomas D Meyer, Steffi Pfeiffer, Sarah Kittel-Schneider, Andreas Reif, Thomas J Stamm, Maren Rottmann-Wolf, Josephine Mathiebe, Eva L Kellmann, Philipp Ritter, Seza Krüger-Özgürdal, Anne Karow, Lene-Marie Sondergeld, Veit Roessner, Cathrin Sauer, Andrea Pfennig
Efficacy of cognitive-behavioral group therapy in patients at risk for serious mental illness presenting with subthreshold bipolar symptoms: Results from a prespecified interim analysis of a multicenter, randomized, controlled study. Bipolar disorders 22 (5) (2020)
Christoph U Correll, Nina R Schooler
Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment. Neuropsychiatric disease and treatment 16 (2020)
Christoph U Correll, Lily Shi, Catherine Weiss, Mary Hobart, Anna Eramo, Ruth A Duffy, Emmanuelle Weiller, Ross A Baker
Successful switching of patients with acute schizophrenia from another antipsychotic to brexpiprazole: comparison of clinicians' choice of cross-titration schedules in a post hoc analysis of a randomized, double-blind, maintenance treatment study. CNS spectrums 24 (5) (2020)
Amanda Krogmann, Luisa Peters, Laura von Hardenberg, Katja Bödeker, Viktor B Nöhles, Christoph U Correll
Keeping up with the therapeutic advances in schizophrenia: a review of novel and emerging pharmacological entities. CNS spectrums 24 (S1) (2020)
Jari Tiihonen, Heidi Taipale, Christoph U Correll
Commentary on Robert Whitaker's viewpoint. Psychological medicine 50 (16) (2020)
Jari Tiihonen, Heidi Taipale, Christoph U Correll
Rejoinder to rejoinder to commentary. Psychological medicine 50 (16) (2020)
Marco Solmi, Michele Fornaro, Kuniyoshi Toyoshima, Andrè F Carvalho, Cristiano A Köhler, Nicola Veronese, Brendon Stubbs, Andrea de Bartolomeis, Christoph U Correll
Systematic review and exploratory meta-analysis of the efficacy, safety, and biological effects of psychostimulants and atomoxetine in patients with schizophrenia or schizoaffective disorder. CNS spectrums 24 (5) (2020)
Konstantinos N Fountoulakis, Hans-Jurgen Moeller, Siegfried Kasper, Carol Tamminga, Shigeto Yamawaki, Rene Kahn, Rajiv Tandon, Christoph U Correll, Afzal Javed
The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia. CNS spectrums (2020)
Christoph U Correll, Thomas Brevig, Cecilia Brain
Exploration of Treatment-Resistant Schizophrenia Subtypes Based on a Survey of 204 US Psychiatrists. Neuropsychiatric disease and treatment 15 (2019)
Davide Papola, Giovanni Ostuzzi, C Gastaldon, G P Morgano, E Dragioti, A F Carvalho, P Fusar-Poli, Christoph U Correll, Marco Solmi, C Barbui
Antipsychotic use and risk of life-threatening medical events: umbrella review of observational studies. Acta psychiatrica Scandinavica 140 (3) (2019)
Christoph U Correll, Thomas Brevig, Cecilia Brain
Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists. BMC psychiatry 19 (1) (2019)
Julie R Larsen, Camilla K Svensson, Louise Vedtofte, Mathilde Lund Jakobsen, Hans Søe Jespersen, Michelle I Jakobsen, Kamuran Koyuncu, Ole Schjerning, Jimmi Nielsen, Claus T Ekstrøm, Jens J Holst, Christoph U Correll, Tina Vilsbøll, Anders Fink-Jensen
High prevalence of prediabetes and metabolic abnormalities in overweight or obese schizophrenia patients treated with clozapine or olanzapine. CNS spectrums 24 (4) (2018)
C K Svensson, J R Larsen, L Vedtofte, M S L Jakobsen, H R Jespersen, Michelle Iris Jakobsen, K Koyuncu, O Schjerning, J Nielsen, C T Ekstrøm, Christoph U Correll, T Vilsbøll, A Fink-Jensen
One-year follow-up on liraglutide treatment for prediabetes and overweight/obesity in clozapine- or olanzapine-treated patients. Acta psychiatrica Scandinavica 139 (1) (2018)
Christoph U Correll, Jennifer Kern Sliwa, Dean M Najarian, Stephen R Saklad
Practical considerations for managing breakthrough psychosis and symptomatic worsening in patients with schizophrenia on long-acting injectable antipsychotics. CNS spectrums 24 (4) (2018)